Crestline Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,306
| Closed | -$3.42M | – | 202 |
|
|
2022
Q4 | $3.42M | Buy |
12,306
+125
| +1% | +$34.8K | 0.5% | 61 |
|
|
2022
Q3 | $2.55M | Buy |
12,181
+5,123
| +73% | +$1.07M | 0.34% | 71 |
|
|
2022
Q2 | $1.66M | Sell |
7,058
-1,601
| -18% | -$377K | 0.22% | 94 |
|
|
2022
Q1 | $1.55M | Sell |
8,659
-11,597
| -57% | -$2.08M | 0.19% | 103 |
|
|
2021
Q4 | $4.38M | Buy |
20,256
+3,014
| +17% | +$651K | 0.33% | 59 |
|
|
2021
Q3 | $3.18M | Buy |
17,242
+5,987
| +53% | +$1.1M | 0.3% | 74 |
|
|
2021
Q2 | $2.02M | Buy |
+11,255
| New | +$2.02M | 0.17% | 81 |
|
|
2019
Q4 | – | Sell |
-37,500
| Closed | -$2.99M | – | 91 |
|
|
2019
Q3 | $2.99M | Buy |
37,500
+24,500
| +188% | +$1.95M | 0.48% | 37 |
|
|
2019
Q2 | $1.02M | Buy |
+13,000
| New | +$1.02M | 0.14% | 59 |
|